nodes	percent_of_prediction	percent_of_DWPC	metapath
Bimatoprost—AKR1C3—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.0389	0.153	CbGpPWpGaD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0278	0.109	CbGpPWpGaD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0208	0.0815	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.0203	0.0798	CbGpPWpGaD
Bimatoprost—PTGER3—respiratory system—chronic obstructive pulmonary disease	0.0187	0.122	CbGeAlD
Bimatoprost—PTGER3—connective tissue—chronic obstructive pulmonary disease	0.0164	0.107	CbGeAlD
Bimatoprost—PTGER3—smooth muscle tissue—chronic obstructive pulmonary disease	0.015	0.098	CbGeAlD
Bimatoprost—PTGFR—respiratory system—chronic obstructive pulmonary disease	0.0149	0.0973	CbGeAlD
Bimatoprost—PTGFR—bronchus—chronic obstructive pulmonary disease	0.0123	0.0801	CbGeAlD
Bimatoprost—PTGFR—smooth muscle tissue—chronic obstructive pulmonary disease	0.012	0.0784	CbGeAlD
Bimatoprost—AKR1C3—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.0117	0.0461	CbGpPWpGaD
Bimatoprost—PTGFR—trachea—chronic obstructive pulmonary disease	0.011	0.0719	CbGeAlD
Bimatoprost—Iloprost—PDE4A—chronic obstructive pulmonary disease	0.0109	0.865	CrCbGaD
Bimatoprost—AKR1C3—bronchus—chronic obstructive pulmonary disease	0.00998	0.0651	CbGeAlD
Bimatoprost—PTGER3—lung—chronic obstructive pulmonary disease	0.00991	0.0646	CbGeAlD
Bimatoprost—AKR1C3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00976	0.0637	CbGeAlD
Bimatoprost—AKR1C3—trachea—chronic obstructive pulmonary disease	0.00896	0.0584	CbGeAlD
Bimatoprost—PTGFR—lung—chronic obstructive pulmonary disease	0.00792	0.0517	CbGeAlD
Bimatoprost—PTGER3—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00678	0.0266	CbGpPWpGaD
Bimatoprost—AKR1C3—lung—chronic obstructive pulmonary disease	0.00644	0.042	CbGeAlD
Bimatoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00507	0.0199	CbGpPWpGaD
Bimatoprost—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.00496	0.0195	CbGpPWpGaD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0041	0.0161	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.00372	0.0146	CbGpPWpGaD
Bimatoprost—AKR1C3—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00363	0.0142	CbGpPWpGaD
Bimatoprost—Cystitis—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.0055	CcSEcCtD
Bimatoprost—Hirsutism—Prednisolone—chronic obstructive pulmonary disease	0.00308	0.00531	CcSEcCtD
Bimatoprost—Arthritis—Tiotropium—chronic obstructive pulmonary disease	0.00305	0.00527	CcSEcCtD
Bimatoprost—Bladder pain—Arformoterol—chronic obstructive pulmonary disease	0.00298	0.00515	CcSEcCtD
Bimatoprost—Bladder pain—Formoterol—chronic obstructive pulmonary disease	0.00298	0.00515	CcSEcCtD
Bimatoprost—AKR1C3—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00298	0.0117	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00294	0.00508	CcSEcCtD
Bimatoprost—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00279	0.00482	CcSEcCtD
Bimatoprost—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00276	0.00477	CcSEcCtD
Bimatoprost—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.00276	0.00476	CcSEcCtD
Bimatoprost—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.0047	CcSEcCtD
Bimatoprost—AKR1C3—Bile acid and bile salt metabolism—ALB—chronic obstructive pulmonary disease	0.00263	0.0103	CbGpPWpGaD
Bimatoprost—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00255	0.00441	CcSEcCtD
Bimatoprost—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00251	0.00434	CcSEcCtD
Bimatoprost—Arthritis—Formoterol—chronic obstructive pulmonary disease	0.00247	0.00426	CcSEcCtD
Bimatoprost—Arthritis—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.00426	CcSEcCtD
Bimatoprost—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00241	0.00416	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.0024	0.00415	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00238	0.00412	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00233	0.00916	CbGpPWpGaD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00233	0.00915	CbGpPWpGaD
Bimatoprost—Infection—Roflumilast—chronic obstructive pulmonary disease	0.0023	0.00398	CcSEcCtD
Bimatoprost—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00228	0.00393	CcSEcCtD
Bimatoprost—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00225	0.00389	CcSEcCtD
Bimatoprost—Hirsutism—Prednisone—chronic obstructive pulmonary disease	0.00223	0.00386	CcSEcCtD
Bimatoprost—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00221	0.00381	CcSEcCtD
Bimatoprost—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00379	CcSEcCtD
Bimatoprost—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00379	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00216	0.00849	CbGpPWpGaD
Bimatoprost—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.00215	0.0037	CcSEcCtD
Bimatoprost—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.0037	CcSEcCtD
Bimatoprost—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00214	0.0037	CcSEcCtD
Bimatoprost—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.0021	0.00362	CcSEcCtD
Bimatoprost—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.0021	0.00362	CcSEcCtD
Bimatoprost—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.00209	0.00361	CcSEcCtD
Bimatoprost—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00357	CcSEcCtD
Bimatoprost—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00357	CcSEcCtD
Bimatoprost—Rhinitis—Tiotropium—chronic obstructive pulmonary disease	0.00206	0.00355	CcSEcCtD
Bimatoprost—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00204	0.00353	CcSEcCtD
Bimatoprost—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.00204	0.00352	CcSEcCtD
Bimatoprost—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00203	0.0035	CcSEcCtD
Bimatoprost—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00349	CcSEcCtD
Bimatoprost—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00349	CcSEcCtD
Bimatoprost—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00348	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.002	0.00346	CcSEcCtD
Bimatoprost—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00199	0.00344	CcSEcCtD
Bimatoprost—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00199	0.00344	CcSEcCtD
Bimatoprost—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00198	0.00342	CcSEcCtD
Bimatoprost—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00337	CcSEcCtD
Bimatoprost—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00195	0.00337	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00192	0.00332	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00192	0.00332	CcSEcCtD
Bimatoprost—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00192	0.00331	CcSEcCtD
Bimatoprost—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00325	CcSEcCtD
Bimatoprost—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00325	CcSEcCtD
Bimatoprost—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00186	0.00322	CcSEcCtD
Bimatoprost—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00186	0.00321	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00185	0.00727	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00319	CcSEcCtD
Bimatoprost—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00184	0.00318	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.00182	0.00716	CbGpPWpGaD
Bimatoprost—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00314	CcSEcCtD
Bimatoprost—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00299	CcSEcCtD
Bimatoprost—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00299	CcSEcCtD
Bimatoprost—Dinoprostone—CYP1A2—chronic obstructive pulmonary disease	0.0017	0.135	CrCbGaD
Bimatoprost—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.0017	0.00293	CcSEcCtD
Bimatoprost—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00291	CcSEcCtD
Bimatoprost—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00168	0.00289	CcSEcCtD
Bimatoprost—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00166	0.00287	CcSEcCtD
Bimatoprost—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00287	CcSEcCtD
Bimatoprost—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00287	CcSEcCtD
Bimatoprost—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00284	CcSEcCtD
Bimatoprost—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00284	CcSEcCtD
Bimatoprost—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00282	CcSEcCtD
Bimatoprost—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00282	CcSEcCtD
Bimatoprost—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00282	CcSEcCtD
Bimatoprost—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00281	CcSEcCtD
Bimatoprost—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00281	CcSEcCtD
Bimatoprost—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00281	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00162	0.00635	CbGpPWpGaD
Bimatoprost—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00278	CcSEcCtD
Bimatoprost—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00161	0.00278	CcSEcCtD
Bimatoprost—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00276	CcSEcCtD
Bimatoprost—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00276	CcSEcCtD
Bimatoprost—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00275	CcSEcCtD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00158	0.00621	CbGpPWpGaD
Bimatoprost—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00158	0.00273	CcSEcCtD
Bimatoprost—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00271	CcSEcCtD
Bimatoprost—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00269	CcSEcCtD
Bimatoprost—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00268	CcSEcCtD
Bimatoprost—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.00266	CcSEcCtD
Bimatoprost—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00265	CcSEcCtD
Bimatoprost—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00265	CcSEcCtD
Bimatoprost—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00153	0.00265	CcSEcCtD
Bimatoprost—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00263	CcSEcCtD
Bimatoprost—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00152	0.00262	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00261	CcSEcCtD
Bimatoprost—AKR1C3—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00151	0.00591	CbGpPWpGaD
Bimatoprost—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00258	CcSEcCtD
Bimatoprost—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00258	CcSEcCtD
Bimatoprost—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00257	CcSEcCtD
Bimatoprost—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00253	CcSEcCtD
Bimatoprost—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00253	CcSEcCtD
Bimatoprost—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.00252	CcSEcCtD
Bimatoprost—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00145	0.00251	CcSEcCtD
Bimatoprost—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00145	0.0025	CcSEcCtD
Bimatoprost—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00143	0.00247	CcSEcCtD
Bimatoprost—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00245	CcSEcCtD
Bimatoprost—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00245	CcSEcCtD
Bimatoprost—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00244	CcSEcCtD
Bimatoprost—Tension—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00244	CcSEcCtD
Bimatoprost—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00243	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00141	0.00554	CbGpPWpGaD
Bimatoprost—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00242	CcSEcCtD
Bimatoprost—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00242	CcSEcCtD
Bimatoprost—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00242	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00138	0.00544	CbGpPWpGaD
Bimatoprost—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00138	0.00238	CcSEcCtD
Bimatoprost—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00137	0.00237	CcSEcCtD
Bimatoprost—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00137	0.00236	CcSEcCtD
Bimatoprost—Cataract—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00236	CcSEcCtD
Bimatoprost—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00136	0.00235	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00136	0.00532	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00136	0.00532	CbGpPWpGaD
Bimatoprost—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00231	CcSEcCtD
Bimatoprost—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00228	CcSEcCtD
Bimatoprost—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00228	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00129	0.00507	CbGpPWpGaD
Bimatoprost—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00128	0.00222	CcSEcCtD
Bimatoprost—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.0022	CcSEcCtD
Bimatoprost—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00128	0.0022	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00217	CcSEcCtD
Bimatoprost—Cough—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00217	CcSEcCtD
Bimatoprost—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00217	CcSEcCtD
Bimatoprost—AKR1C3—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00126	0.00493	CbGpPWpGaD
Bimatoprost—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00216	CcSEcCtD
Bimatoprost—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00215	CcSEcCtD
Bimatoprost—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00215	CcSEcCtD
Bimatoprost—Cough—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00213	CcSEcCtD
Bimatoprost—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00212	CcSEcCtD
Bimatoprost—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00212	CcSEcCtD
Bimatoprost—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00211	CcSEcCtD
Bimatoprost—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00211	CcSEcCtD
Bimatoprost—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00211	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00211	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00211	CcSEcCtD
Bimatoprost—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00208	CcSEcCtD
Bimatoprost—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00207	CcSEcCtD
Bimatoprost—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00207	CcSEcCtD
Bimatoprost—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00207	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00206	CcSEcCtD
Bimatoprost—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00205	CcSEcCtD
Bimatoprost—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00205	CcSEcCtD
Bimatoprost—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00203	CcSEcCtD
Bimatoprost—PTGFR—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00117	0.0046	CbGpPWpGaD
Bimatoprost—Infection—Formoterol—chronic obstructive pulmonary disease	0.00117	0.00202	CcSEcCtD
Bimatoprost—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00117	0.00202	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00116	0.00456	CbGpPWpGaD
Bimatoprost—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.002	CcSEcCtD
Bimatoprost—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.002	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00116	0.00454	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00199	CcSEcCtD
Bimatoprost—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00199	CcSEcCtD
Bimatoprost—AKR1C3—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00115	0.00453	CbGpPWpGaD
Bimatoprost—PTGER1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.00115	0.00451	CbGpPWpGaD
Bimatoprost—Infection—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00198	CcSEcCtD
Bimatoprost—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00197	CcSEcCtD
Bimatoprost—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00197	CcSEcCtD
Bimatoprost—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00196	CcSEcCtD
Bimatoprost—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00195	CcSEcCtD
Bimatoprost—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00193	CcSEcCtD
Bimatoprost—Infection—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00191	CcSEcCtD
Bimatoprost—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00189	CcSEcCtD
Bimatoprost—AKR1C3—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00109	0.00429	CbGpPWpGaD
Bimatoprost—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00188	CcSEcCtD
Bimatoprost—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00186	CcSEcCtD
Bimatoprost—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00184	CcSEcCtD
Bimatoprost—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00184	CcSEcCtD
Bimatoprost—PTGER3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00106	0.00416	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00105	0.00414	CbGpPWpGaD
Bimatoprost—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00181	CcSEcCtD
Bimatoprost—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00181	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00105	0.00412	CbGpPWpGaD
Bimatoprost—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00181	CcSEcCtD
Bimatoprost—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00181	CcSEcCtD
Bimatoprost—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00104	0.0018	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00104	0.00408	CbGpPWpGaD
Bimatoprost—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00179	CcSEcCtD
Bimatoprost—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00179	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00103	0.00405	CbGpPWpGaD
Bimatoprost—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00103	0.00178	CcSEcCtD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00103	0.00403	CbGpPWpGaD
Bimatoprost—PTGFR—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.00103	0.00403	CbGpPWpGaD
Bimatoprost—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00177	CcSEcCtD
Bimatoprost—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00177	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00102	0.00175	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.00175	CcSEcCtD
Bimatoprost—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00175	CcSEcCtD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00101	0.00398	CbGpPWpGaD
Bimatoprost—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00174	CcSEcCtD
Bimatoprost—Pain—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00174	CcSEcCtD
Bimatoprost—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00174	CcSEcCtD
Bimatoprost—PTGER1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.001	0.00394	CbGpPWpGaD
Bimatoprost—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000996	0.00172	CcSEcCtD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000993	0.0039	CbGpPWpGaD
Bimatoprost—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000991	0.00171	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000989	0.00388	CbGpPWpGaD
Bimatoprost—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000988	0.00171	CcSEcCtD
Bimatoprost—Pain—Montelukast—chronic obstructive pulmonary disease	0.000986	0.0017	CcSEcCtD
Bimatoprost—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000979	0.00169	CcSEcCtD
Bimatoprost—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000976	0.00168	CcSEcCtD
Bimatoprost—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000975	0.00168	CcSEcCtD
Bimatoprost—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000969	0.00167	CcSEcCtD
Bimatoprost—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000965	0.00167	CcSEcCtD
Bimatoprost—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00096	0.00166	CcSEcCtD
Bimatoprost—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000951	0.00164	CcSEcCtD
Bimatoprost—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00092	0.00159	CcSEcCtD
Bimatoprost—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000919	0.00159	CcSEcCtD
Bimatoprost—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000919	0.00159	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000917	0.0036	CbGpPWpGaD
Bimatoprost—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000914	0.00158	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000908	0.00357	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000898	0.00353	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000898	0.00352	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000892	0.0035	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000885	0.00347	CbGpPWpGaD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000869	0.00341	CbGpPWpGaD
Bimatoprost—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000867	0.0015	CcSEcCtD
Bimatoprost—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000865	0.00149	CcSEcCtD
Bimatoprost—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000864	0.00149	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000864	0.00339	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.00085	0.00334	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000846	0.00332	CbGpPWpGaD
Bimatoprost—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000845	0.00146	CcSEcCtD
Bimatoprost—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000845	0.00146	CcSEcCtD
Bimatoprost—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000833	0.00144	CcSEcCtD
Bimatoprost—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000833	0.00144	CcSEcCtD
Bimatoprost—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00143	CcSEcCtD
Bimatoprost—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000816	0.00141	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000816	0.0032	CbGpPWpGaD
Bimatoprost—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000798	0.00138	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000797	0.00313	CbGpPWpGaD
Bimatoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000793	0.00311	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000791	0.0031	CbGpPWpGaD
Bimatoprost—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000787	0.00136	CcSEcCtD
Bimatoprost—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000781	0.00135	CcSEcCtD
Bimatoprost—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000779	0.00134	CcSEcCtD
Bimatoprost—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000779	0.00134	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000776	0.00305	CbGpPWpGaD
Bimatoprost—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000776	0.00305	CbGpPWpGaD
Bimatoprost—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000763	0.00132	CcSEcCtD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00076	0.00298	CbGpPWpGaD
Bimatoprost—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00128	CcSEcCtD
Bimatoprost—Rash—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00128	CcSEcCtD
Bimatoprost—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000742	0.00128	CcSEcCtD
Bimatoprost—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000742	0.00128	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000739	0.0029	CbGpPWpGaD
Bimatoprost—Headache—Formoterol—chronic obstructive pulmonary disease	0.000738	0.00127	CcSEcCtD
Bimatoprost—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000738	0.00127	CcSEcCtD
Bimatoprost—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000736	0.00127	CcSEcCtD
Bimatoprost—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00127	CcSEcCtD
Bimatoprost—Rash—Montelukast—chronic obstructive pulmonary disease	0.000727	0.00126	CcSEcCtD
Bimatoprost—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000727	0.00125	CcSEcCtD
Bimatoprost—Depression—Prednisone—chronic obstructive pulmonary disease	0.000724	0.00125	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000724	0.00284	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000724	0.00284	CbGpPWpGaD
Bimatoprost—Headache—Montelukast—chronic obstructive pulmonary disease	0.000723	0.00125	CcSEcCtD
Bimatoprost—PTGER3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000706	0.00277	CbGpPWpGaD
Bimatoprost—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000702	0.00121	CcSEcCtD
Bimatoprost—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000701	0.00121	CcSEcCtD
Bimatoprost—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.0007	0.00121	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.0007	0.00275	CbGpPWpGaD
Bimatoprost—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000699	0.00121	CcSEcCtD
Bimatoprost—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000699	0.00121	CcSEcCtD
Bimatoprost—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000697	0.0012	CcSEcCtD
Bimatoprost—PTGER3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000692	0.00272	CbGpPWpGaD
Bimatoprost—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000685	0.00118	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000679	0.00267	CbGpPWpGaD
Bimatoprost—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000675	0.00116	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000671	0.00264	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000665	0.00261	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000662	0.0026	CbGpPWpGaD
Bimatoprost—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00066	0.00114	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000657	0.00258	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000648	0.00254	CbGpPWpGaD
Bimatoprost—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000641	0.00111	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000636	0.0025	CbGpPWpGaD
Bimatoprost—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00061	0.00105	CcSEcCtD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000596	0.00234	CbGpPWpGaD
Bimatoprost—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000592	0.00102	CcSEcCtD
Bimatoprost—PTGFR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000591	0.00232	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000591	0.00232	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000586	0.0023	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000583	0.00229	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000579	0.00227	CbGpPWpGaD
Bimatoprost—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000577	0.000996	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—GC—chronic obstructive pulmonary disease	0.000575	0.00226	CbGpPWpGaD
Bimatoprost—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000568	0.00098	CcSEcCtD
Bimatoprost—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000561	0.0022	CbGpPWpGaD
Bimatoprost—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.000941	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000541	0.00212	CbGpPWpGaD
Bimatoprost—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000535	0.000924	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000535	0.0021	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.00053	0.00208	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00053	0.00208	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000523	0.00205	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000517	0.00203	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000512	0.00201	CbGpPWpGaD
Bimatoprost—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00051	0.000881	CcSEcCtD
Bimatoprost—PTGER1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000506	0.00199	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.0005	0.00196	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000494	0.00194	CbGpPWpGaD
Bimatoprost—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00049	0.000846	CcSEcCtD
Bimatoprost—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000482	0.000832	CcSEcCtD
Bimatoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00048	0.000829	CcSEcCtD
Bimatoprost—Infection—Prednisone—chronic obstructive pulmonary disease	0.00046	0.000795	CcSEcCtD
Bimatoprost—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000784	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000454	0.00178	CbGpPWpGaD
Bimatoprost—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00045	0.000777	CcSEcCtD
Bimatoprost—PTGER3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000447	0.00175	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000428	0.00168	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000427	0.00168	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000426	0.00167	CbGpPWpGaD
Bimatoprost—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.000728	CcSEcCtD
Bimatoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.00042	0.00165	CbGpPWpGaD
Bimatoprost—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000723	CcSEcCtD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000414	0.00163	CbGpPWpGaD
Bimatoprost—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000411	0.00161	CbGpPWpGaD
Bimatoprost—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000408	0.000704	CcSEcCtD
Bimatoprost—PTGER3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000406	0.00159	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000405	0.00159	CbGpPWpGaD
Bimatoprost—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000402	0.000694	CcSEcCtD
Bimatoprost—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000402	0.000693	CcSEcCtD
Bimatoprost—Headache—Prednisolone—chronic obstructive pulmonary disease	0.0004	0.00069	CcSEcCtD
Bimatoprost—PTGFR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000397	0.00156	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000391	0.00153	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000388	0.00152	CbGpPWpGaD
Bimatoprost—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000379	0.000654	CcSEcCtD
Bimatoprost—AKR1C3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000375	0.00147	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000374	0.00147	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000366	0.00144	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000355	0.00139	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.00034	0.00133	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000334	0.00131	CbGpPWpGaD
Bimatoprost—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000332	0.000574	CcSEcCtD
Bimatoprost—PTGER1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000332	0.0013	CbGpPWpGaD
Bimatoprost—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000328	0.000566	CcSEcCtD
Bimatoprost—PTGER1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000327	0.00128	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00032	0.00126	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00032	0.00125	CbGpPWpGaD
Bimatoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000318	0.00125	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—HDAC2—chronic obstructive pulmonary disease	0.000315	0.00124	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000314	0.00123	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000313	0.00123	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000313	0.00123	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000313	0.00123	CbGpPWpGaD
Bimatoprost—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000312	0.00122	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000311	0.00122	CbGpPWpGaD
Bimatoprost—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000306	0.000529	CcSEcCtD
Bimatoprost—PTGFR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000303	0.00119	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000302	0.00119	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000297	0.00117	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—KL—chronic obstructive pulmonary disease	0.000293	0.00115	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000292	0.00115	CbGpPWpGaD
Bimatoprost—Rash—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000504	CcSEcCtD
Bimatoprost—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000504	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000291	0.00114	CbGpPWpGaD
Bimatoprost—Headache—Prednisone—chronic obstructive pulmonary disease	0.00029	0.000501	CcSEcCtD
Bimatoprost—AKR1C3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.00029	0.00114	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000286	0.00112	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000283	0.00111	CbGpPWpGaD
Bimatoprost—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000275	0.000475	CcSEcCtD
Bimatoprost—PTGER3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000268	0.00105	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000265	0.00104	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000261	0.00102	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.00026	0.00102	CbGpPWpGaD
Bimatoprost—PTGER3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000241	0.000948	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00024	0.000941	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000234	0.000918	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000229	0.000898	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000221	0.000867	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—ERBB3—chronic obstructive pulmonary disease	0.00022	0.000863	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000219	0.000861	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000218	0.000855	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000218	0.000855	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000217	0.000853	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000215	0.000843	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000213	0.000835	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00021	0.000823	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000205	0.000806	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000201	0.000787	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.0002	0.000786	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000196	0.000771	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000195	0.000765	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00019	0.000745	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000189	0.000744	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS2—chronic obstructive pulmonary disease	0.000183	0.000719	CbGpPWpGaD
Bimatoprost—PTGFR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000181	0.000709	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000179	0.000704	CbGpPWpGaD
Bimatoprost—PTGER1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000177	0.000694	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000175	0.000689	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000169	0.000665	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000164	0.000644	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000163	0.00064	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000161	0.00063	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.00016	0.000629	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000159	0.000626	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000157	0.000616	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000154	0.000606	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000154	0.000604	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000153	0.000603	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000153	0.000601	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000148	0.000581	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—NOS3—chronic obstructive pulmonary disease	0.000147	0.000578	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000146	0.000573	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000146	0.000572	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000143	0.00056	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000138	0.00054	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.00013	0.000509	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—ALB—chronic obstructive pulmonary disease	0.000129	0.000506	CbGpPWpGaD
Bimatoprost—AKR1C3—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000123	0.000484	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000123	0.000484	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.00012	0.000471	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000117	0.000461	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000117	0.00046	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000114	0.000449	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000112	0.00044	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000109	0.000429	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000108	0.000424	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000107	0.00042	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000105	0.000413	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000103	0.000405	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—TGFB1—chronic obstructive pulmonary disease	9.74e-05	0.000382	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.69e-05	0.00038	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.66e-05	0.000379	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—EGFR—chronic obstructive pulmonary disease	9.55e-05	0.000375	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.48e-05	0.000372	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.47e-05	0.000372	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.21e-05	0.000362	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.15e-05	0.000359	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.02e-05	0.000354	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.76e-05	0.000344	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.58e-05	0.000337	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.27e-05	0.000325	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.95e-05	0.000312	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.87e-05	0.000309	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.7e-05	0.000302	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.43e-05	0.000292	CbGpPWpGaD
Bimatoprost—AKR1C3—Disease—IL6—chronic obstructive pulmonary disease	7.34e-05	0.000288	CbGpPWpGaD
Bimatoprost—PTGER3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.28e-05	0.000286	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.22e-05	0.000284	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.08e-05	0.000278	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.07e-05	0.000278	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.93e-05	0.000272	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.82e-05	0.000268	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.69e-05	0.000263	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.94e-05	0.000233	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.82e-05	0.000228	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.61e-05	0.00022	CbGpPWpGaD
Bimatoprost—PTGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.44e-05	0.000214	CbGpPWpGaD
Bimatoprost—PTGER1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.33e-05	0.000209	CbGpPWpGaD
Bimatoprost—AKR1C3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.14e-05	0.000202	CbGpPWpGaD
